U.S. accuses Israel's Teva of fixing drug prices
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva looks to amp up research collaborations, CEO says
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva CEO Jeremy Levin steps down amid board squabble | Fierce Pharma
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Five Things Facing Teva's New CEO Richard Francis :: Generics Bulletin
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva CEO exits amid crisis of confidence at drugmaker | Fox Business
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Invest, don't protest' ex-Teva CEO warns biosimilar detractors
Teva Punished After Weak Outlook (NYSE:TEVA) | Seeking Alpha
Richard Francis - President and Chief Executive Officer - Teva Pharmaceuticals | LinkedIn
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Erez Vigodman steps down as Teva CEO
Teva CEO on decimated share price: "It's rational enough from a market point of view" — MedWatch
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
